Market Analysis
Asthma inhalers are easily portable and hand-held that are used to deliver medicine to the lungs. To treat or prevent diseases of the airways including asthma, Inhaler devices are used. A variety of asthma inhalers are available to help control asthma symptoms such as metered-dose inhalers, dry powder inhalers, and soft mist inhalers (SMIs). Inhaler devices have been proved to be the safest and most effective way to treat and control asthma and other respiratory diseases, as the inhaled medication reaches the lungs directly.

The factors leading to the growth of the global asthma inhaler device market are rising the frequency of asthma, rising need for rescue medication, and rising the demand for metered-dose inhalers. However, technical problems with inhaler devices and side-effects and complications during inhalation are the posing hurdles to the market growth on the global level.

Market Segmentation
The asthma inhaler device market, based on item type, continues to be segmented into metered dose inhalers, dry powder inhalers, soft mist inhalers. The asthma inhaler device markets, based on mode of operation, have been segmented into the manually operated inhaler devices and digitally operated inhaler devices. Based on end user, the market is segmented into hospitals and clinics, homecare and others.

Regional analysis
Based on region the global asthma inhaler device market is divided up into the Americas, Europe, Asia-Pacific, and also the Middle East and Africa. The Americas is expected to command the largest market share due to adoption of smart inhalers by the population and rising health expenditure by per person. These factors are driving the growth of the market in the Americas. Europe accounts for the second-largest market share in the global asthma inhaler device market. The European market is divided into Western Europe and Eastern Europe.

Western Europe is anticipated to dominate the market growth in Europe owing to the presence of developed countries such as UK, Germany, France, Italy and others. UK kept a share of 26.8% within the Western Europe asthma inhaler device marketplace in 2018. Asia-Pacific is anticipated to be the fastest growing market with a CAGR of 7.28% for 2018. The high prevalence of respiratory diseases such as asthma is expected to drive the market growth in this region. Moreover, the Middle Eastern and Africa holds the least market share but the increasing cases of asthma and demand for better treatments in countries supports the market growth.

Major players
Development of news product, innovation, and strategic collaboration are few crucial techniques followed by the global players operating in the asthma inhaler device market. The major key players in the global asthma inhaler device market are- Medisol Lifescience Pvt. Ltd (India), Beximco Pharmaceuticals Ltd (Bangladesh), Koninklijke Philips NV (Netherlands), AstraZeneca (UK), Cipla Inc. (India), GlaxoSmithKline PLC (UK), Boehringer Ingelheim International GmbH (Germany), Teva Pharmaceutical Industries Ltd (Israel), Merck & Co., Inc. (US), CHIESI Farmaceutici SpA (Italy) as well as others.